STUDY OF BUDESONIDE NEBULIZING SUSPENSION & PLACEBO IN ASTHMATIC CHILDREN

该研究将评估布地奈德雾化吸入的有效性和安全性 暂停，6个月至8岁以下儿童 中度至重度哮喘。该试验是一种双盲安慰剂- 对照试验、剂量试验、疗效试验和安全性试验。在…的过程中 治疗后，患者将接受肺功能测试和 筛选实验室研究。 此外，对下丘脑-垂体-肾上腺轴功能的评估 将与包括Cortosyn在内的基线实验室研究一起完成 刺激测试。

The study will evaluate the efficacy and safety of budesonide nebulizing suspension, in children between the ages of 6 months and 8 years with moderate to severe asthma. The trial is a double blind placebo- controlled, dosage, efficacy and safety trial. During the course of treatment, patients will be evaluated with pulmonary function tests and screening laboratory studies. Additionally, assessment of hypothalamic-pituitary-adrenal axis function will be done with baseline laboratory studies, including Cortosyn stimulation testing.